Skip to main content

Almitas Capital LLC

SEC CIK
0001596468
Latest filing
Aug 14, 2026

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by Almitas Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2025
Holdings of ADAPY by Almitas Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−109,054−100.0%Sold outHolders
Q2 2025109,054$26.1K<0.1%+109,054NewHolders